Home
About
Why D4DPR?
Strategic Vision
Platform of Regulations
Leadership
D4DPR Experts
D4DPR Updates
Advocacy
Media
Expert Testimony
Coalition Partners
Education
Cannabis Curriculums
Regulation & Public Health
Harms of Prohibition
Myths, Risks & Uncertainties
Resources
Ask a Question
Regulation
Universal Cannabis Symbol
JOIN
DONATE
Home
Categories
Expert Testimony
Expert Testimony
Expert Testimony
Opposing the Colorado Board of Health Proposed Rules for Allowing Greater than 0.3% THC Hemp Products
11/16/23
Expert Testimony
Supporting Delaware’s Adult Use Cannabis Program (HB 23-2)
1/24/23
Expert Testimony
Opposing Maryland’s Cannabis-induced Psychosis and THC Concentration Limit (HB 23-1147)
3/1/23
Expert Testimony
Supporting Hawaii’s Adult Use Cannabis Program (SB375)
2/17/23
Expert Testimony
Supporting Colorado’s Access to Medical Marijuana (SB-081)
2/17/23
D4DPR Updates
D4DPR Publishes White Paper on Legislating Cannabis Use in Healthcare Facilities
2/17/23
Expert Testimony
Supporting Maryland’s Adult Use Cannabis Program (HB556)
2/16/23
Expert Testimony
Supporting Kansas’ Medical Cannabis Program (SB 560)
6/29/22
Expert Testimony
Supporting Override of Delaware’s Governor Veto of Adult Use Cannabis Program (HB 371)
6/2/22
Expert Testimony
Supporting the U.S. House Ending the Federal Prohibition of Cannabis - The MORE Act
2/24/22
Expert Testimony
Supporting Delaware’s Adult Use Cannabis Program (HB 305)
1/26/22
Expert Testimony
New Jersey Senate Judiciary SB2703
11/1/18
Expert Testimony
US Senate Cannabis Administration and Opportunity Act
1/1/21
Expert Testimony
New York General Assembly
12/1/18
Expert Testimony
South Carolina Medical Affairs S.366
4/1/19
Expert Testimony
Supporting Alabama’s Medical Cannabis Program (SB 46)
4/26/21
Expert Testimony
Alabama House SB165
1/1/20
Expert Testimony
Alabama House SB165
1/1/20
Expert Testimony
Alabama House SB165
1/1/20
Expert Testimony
Opposing Colorado’s Cannabis Potency Cap (HB 21-1317)
5/18/21
Expert Testimony
Colorado Senate Medical Marijuana Code SB218
5/10/19
Expert Testimony
Comments in Response to the Cannabis Administration and Opportunity Act (CAOA)
1/1/21
Expert Testimony
Testimony before the Illinois Senate on Marijuana Legalization
1/22/18
Expert Testimony
Supporting the U.S. House Ending the Federal Prohibition of Cannabis - The MORE Act
10/1/21
Expert Testimony
Testimony to New Jersey’s Cannabis Regulatory Commission
6/2/21
Expert Testimony
Supporting Texas’ Penalty Reduction for Cannabis Possession (HB 3772)
Bryon Adinoff, MD
4/20/21
Expert Testimony
Supporting Delaware’s Adult Use Cannabis Program (HB 150)
Bryon Adinoff, MD
3/24/21
Expert Testimony
Supporting Delaware’s Adult Use Cannabis Program (HB 150)
David L. Nathan, MD, DFAPA
3/24/21
Expert Testimony
New Jersey Assembly Oversight, Reform and Federal Relations
David L. Nathan, MD, DFAPA
11/10/20
Expert Testimony
New Jersey Assembly Appropriations: Regulations
David L. Nathan, MD, DFAPA
11/20/20
Expert Testimony
Supporting Connecticut’s Adult Use Cannabis Program (SB 888)
Bryon Adinoff, MD
2/25/21
Expert Testimony
New York Legislature CRTA
Tanya Adams, DO
2/23/21
Expert Testimony
Supporting Connecticut’s Adult Use Cannabis Program (SB 888)
Hugh Blumenfeld, MD, PhD
3/1/21
Expert Testimony
New Jersey Senate Judiciary AB1898
David L. Nathan, MD, DFAPA
2/22/21
Expert Testimony
Virginia Senate: Adult Use Cannabis
Bryon Adinoff, MD
1/31/21
Expert Testimony
New Jersey Senate Judiciary Cannabis Adult Use
David L. Nathan, MD, DFAPA
6/19/17
Expert Testimony
New Jersey General Assembly CR840
Monica Taing, PharmD
12/12/19
Expert Testimony
California State Assembly AB1606
D4DPR
4/14/17
Expert Testimony
Vermont House Government Operations SB54
David L. Nathan, MD, DFAPA
4/30/19
Expert Testimony
Connecticut Senate Judiciary SB16
David L. Nathan, MD, DFAPA
3/3/20
Expert Testimony
Kansas Senate Federal and State Affairs SB366
Wendy Askew, MD
10/23/19
Expert Testimony
Kansas Senate Federal and State Affairs SB366
Rachel Knox, MD
10/23/19
Expert Testimony
Kansas Senate Federal and State Affairs SB366
Donald O. Lyman, MD, DTPH
10/23/19
Expert Testimony
Kansas Senate Federal and State Affairs SB366
Genester Wilson-King, MD, FACOG
10/23/19
Expert Testimony
Kansas Senate Federal and State Affairs SB366
Bryon Adinoff, MD
10/23/19
Expert Testimony
Connecticut Senate Judiciary SB16
Bryon Adinoff, MD
3/3/20
Expert Testimony
US House Subcommittee Cannabis Policies for the New Decade
David L. Nathan, MD, DFAPA
1/18/20
Expert Testimony
Texas House Criminal Jurisprudence HB63
Bryon Adinoff, MD
3/4/19
Expert Testimony
Vermont Senate Judiciary SB54
David L. Nathan, MD, DFAPA
2/1/19
Expert Testimony
Rhode Island House Judiciary HB5555
David L. Nathan, MD, DFAPA
4/12/17
Expert Testimony
New York Assembly Codes, Health, Governmental Operations, Alcoholism and Drug Abuse
David L. Nathan, MD, DFAPA
10/17/18
Expert Testimony
New Jersey Senate Judiciary SB2703
David L. Nathan, MD, DFAPA
3/19/19
Expert Testimony
New Jersey Assembly Oversight, Reform and Federal Relations Committee on Cannabis Legalization
David L. Nathan, MD, DFAPA
3/6/18
Expert Testimony
New Jersey Division of Consumer Affairs Marijuana Reclassification
David L. Nathan, MD, DFAPA
4/25/18
Expert Testimony
New Jersey Senate Judiciary
David L. Nathan, MD, DFAPA
11/17/15
Expert Testimony
Illinois General Assembly SB316
David L. Nathan, MD, DFAPA
1/23/18
Expert Testimony
Delaware House Revenue & Finance HB110
David L. Nathan, MD, DFAPA
5/11/17
Expert Testimony
Vermont House Human Services H.170
Bryon Adinoff, MD
4/12/17
Expert Testimony
Texas House Criminal Jurisprudence HB2107
Bryon Adinoff, MD
5/3/17
Expert Testimony
Texas House Criminal Jurisprudence HB81
Bryon Adinoff, MD
3/14/17
Expert Testimony
Delaware House Revenue & Finance HB110
Bryon Adinoff, MD
6/5/19
Expert Testimony
South Carolina Medical Affairs S.366
Bryon Adinoff, MD
4/6/19
Expert Testimony
Texas House Public Health HB1365
Bryon Adinoff, MD
3/16/19
Expert Testimony
U.S. FDA Cannabis Scheduling
David L. Nathan, MD, DFAPA
4/23/18
Expert Testimony
Connecticut Commission on Women, Children and Seniors Cannabis Forum (Video)
David L. Nathan, MD, DFAPA
4/30/18
Expert Testimony
U.S. House: Congressional Committee Hearing on Cannabis Legalization
David L. Nathan, MD, DFAPA
7/10/19
Categories
Expert Testimony
D4DPR Updates
Media
Education
Browse by Location
Alabama
California
Colorado
Connecticut
Delaware
Federal
Hawaii
Illinois
International
Kansas
Maryland
Montana
New Jersey
New York
Pennsylvania
Rhode Island
South Carolina
Texas
Vermont
Virginia